New analogues of AHMA as potential antitumor agents: synthesis and biological activity.

A series of new analogues of 3-(9-acridinylamino)-5-hydroxymethylaniline (AHMA, 1) and AHMA-ethylcarbamate (2) were synthesized by introducing an O-alkylcarboxylic acid esters to the CH(2)OH function, displacing the CH(2)OH function with a dimethylaminocarboxamido group or with a methyl function introduced at the meta-, para- or ortho-position to the NH(2) group to form 5-(9-acridinylamino)-m-toluidines (AMTs), 5-(9-acridinylamino)-p-toluidines (APTs) or 5-(9-acridinylamino)-o-toluidines (AOTs), respectively. The inhibitions of a variety of human tumor cell growth, interactions with DNA as well as inhibitory effect against topoisomerase II (Topo II) of these new agents were studied. Among AMT, APT and AOT derivatives with dimethylaminoethylcarboxamido and Me at C4 and C5 of acridine moiety (i.e., 21c, 23c and 26c) were more cytotoxic than AHMA (1) and AHMA-ethylcarbamate (2), depending upon the tumor cell line tested. Detailed structure-activity relationships of the new analogues were studied.

[1]  T. Chou,et al.  9-substituted acridine derivatives with long half-life and potent antitumor activity: synthesis and structure-activity relationships. , 1995, Journal of medicinal chemistry.

[2]  L. Malspeis,et al.  Metabolism of 4'-(9-acridinylamino)methanesulfon-m-anisidide by rat liver microsomes. , 1984, Cancer research.

[3]  L. Liu,et al.  DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. , 1986, Cancer research.

[4]  G. Atwell,et al.  Potential antitumor agents. 14. Acridylmethanesulfonanilides. , 1974, Journal of medicinal chemistry.

[5]  T C Chou,et al.  Synthesis and structure-activity relationships of potential anticancer agents: alkylcarbamates of 3-(9-acridinylamino)-5-hydroxymethylaniline. , 1999, Journal of medicinal chemistry.

[6]  A. Leo,et al.  Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents. , 1982, Journal of medicinal chemistry.

[7]  G. Atwell,et al.  Potential antitumor agents. 12. 9-Anilinoacridines. , 1972, Journal of medicinal chemistry.

[8]  W. Denny,et al.  Potential antitumor agents. 34. Quantitative relationships between DNA binding and molecular structure for 9-anilinoacridines substituted in the anilino ring. , 1981, Journal of medicinal chemistry.

[9]  L. Liu,et al.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[10]  T. Chou,et al.  Synergism and antagonism in chemotherapy , 1991 .

[11]  B. Palmer,et al.  Differences in the metabolism of the antitumour agents amsacrine and its derivative CI-921 in rat and mouse. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[12]  A. Montecucco,et al.  DNA unwinding and inhibition of T4 DNA ligase by anthracyclines. , 1988, Nucleic acids research.

[13]  Yves Pommier,et al.  DNA interaction and topoisomerase II inhibition by the antitumor agent 3'-(9-acridinylamino)-5'-hydroxymethylaniline and derivatives , 1996 .

[14]  H. Nakano,et al.  Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus. , 1991, Biochemistry.

[15]  W. Denny,et al.  Potential antitumor agents. 35. Quantitative relationships between antitumor (L1210) potency and DNA binding for 4'-(9-acridinylamino)methanesulfon-m-anisidide analogues. , 1981, Journal of medicinal chemistry.

[16]  W. Denny,et al.  Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide. , 1984, Cancer research.

[17]  W. Denny,et al.  Potential antitumor agents. 46. Structure-activity relationships for acridine monosubstituted derivatives of the antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide. , 1986, Journal of medicinal chemistry.

[18]  C. Hansch,et al.  Quantitative structure-activity relationships (QSAR) for 9-anilinoacridines: a comparative analysis. , 1998, Chemico-biological interactions.

[19]  H. M. Sobell,et al.  Visualization of drug-nucleic acid interactions at atomic resolution. IV. Structure of an aminoacridine--dinucleoside monophosphate crystalline complex, 9-aminoacridine--5-iodocytidylyl (3'--5') guanosine. , 1979, Journal of molecular biology.

[20]  D. Scudiero,et al.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.

[21]  L. Liu,et al.  Cleavage of DNA by mammalian DNA topoisomerase II. , 1983, The Journal of biological chemistry.

[22]  K. Kohn,et al.  Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity. , 1988, Cancer research.

[23]  L. Liu,et al.  Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. , 1988, Cancer research.

[24]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.

[25]  F. Della Seta,et al.  Structure of RNA polymerase II promoters. Conformational alterations and template properties of circularized Saccharomyces cerevisiae GAL1‐GAL10 divergent promoters. , 1986, The EMBO journal.

[26]  Y. Pommier,et al.  Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells. , 1985, Cancer research.

[27]  Jang-Yang Chang,et al.  Antitumor AHMA linked to DNA minor groove binding agents: synthesis and biological evaluation. , 2002, Journal of medicinal chemistry.

[28]  W. Denny,et al.  Potential antitumor agents. 27. Quantitative structure--antileukemic (L1210) activity relationships for the omega-[4-(9-acridinylamino)phenyl]alkanoic acids. , 1978, Journal of medicinal chemistry.